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Background: To analyze the clinical application of endoscope with narrow-band imaging (NBI) system in detecting
high-grade dysplasia, carcinoma in situ, and carcinoma in oral erythroplakia.
Methods: The demographic, histopathological data, and NBI vasculature architectures of patients receiving surgical
intervention for oral erythroplakia were retrospectively reviewed and analyzed statistically.
Results: A total of 72 patients, including 66 males and 6 females, with mean age of 54.6 ± 11.2 years, were enrolled.
The odds ratio of detecting high-grade dysplasia, carcinoma in situ, and carcinoma by twisted elongated morphology
and destructive pattern of intraepithelial microvasculature was 15.46 (confidence interval 95 %: 3.81–72.84), and the
sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 80.95 %, 78.43 %, 60.71 %,
90.91 %, and 79.17 %, respectively, which were significantly better than other two established NBI criteria (p< 0.001).
Conclusions: Twisted, elongated, and destructive patterns of intraepithelial papillary capillary loop of NBI images are
indicators for high-grade dysplasia, carcinoma in situ, and invasive carcinoma in oral erythroplakia.
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Oral cancer incidence has been increasing dramatically
over the past few decades, becoming the eighth most
common cancer worldwide. The incidence rate of oral
cavity cancer is higher for males than for females, and
more common in developing than in developed coun-
tries [1]. A number of studies have reported that oral
squamous cell carcinoma (OSCC) are frequently pre-
ceded by or associated with leukoplakia or erythroplakia.
Furthermore, it has been shown that leukoplakia and
erythroplakia are frequently seen adjacent to some OSCC
[2]. The most common potentially malignant disorders
include leukoplakia, erythroplakia, lichen planus, and sub-
mucous fibrosis. Oral erythroplakia is the rarer form of oral
pre-malignant lesion and has been identified as the one* Correspondence: sweeyang@gmail.com
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However, none of predicting factors of high-grade dys-
plasia, or carcinoma has been disclosed before the
pathology is available.
Flexible fiberoptic endoscope with narrow-band im-
aging system (NBI) is an advanced optical image en-
hancement technology that magnified patterns of the
surface of mucosa and vessels in the surface of mucosa
by employing the characteristics of light spectrum [4]. In
addition to the clinical application for detecting precan-
cerous and neoplastic lesions in oropharynx, hypophar-
ynx, larynx, esophagus, stomach, and colon, this newly
invented endoscopic technique has been shown to sup-
port the evaluation of oral mucosa diseases [5–11].
Histopathologically, erythroplakia commonly shows epi-
thelial change, ranging from dysplasia to invasive carcin-
oma [12,13]. There is evidence to support the viewpoint
that in an individual lesion, the more severe the dyspla-
sia the greater the possibility of it developing into malig-
nancy [14]. Under such circumstances, identification ofhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cinoma (HGD/Tis/CA) within erythroplakia is crucial
and beneficial clinically. Our previous works have indi-
cated that the diversiform intraepithelial microvascular
morphological patterns detected by NBI are advanta-
geous in identifying HGD/Tis/CA in oral leukoplakia
[5,6,8,9]. The aim of this study is to analyze if the
current established criteria used to depict neoplastic le-
sions of the mucosa of the upper aerodigestive tract can
also be used in patients with oral erythroplakia, and to
evaluate the diagnostic validity of NBI in detecting
HGD/Tis/CA in oral erythroplakia.
Methods
This study was approved by the Institutional Review
Board of Chang Gung Memorial Hospital. Records of
patients with oral erythroplakia that underwent flexible
endoscopy with broad-band white light (BWL) and NBI
at the department of otolaryngology of Chang Gung Me-
morial Hospital, Keelung, from April 2009 to Apr 2012
were retrospectively reviewed. Examinations were car-
ried out with an ENF type V2 and type VQ (Olympus
Medical Systems Corp., Tokyo, Japan) NBI endoscope.
One light source was utilized as the standard optical
filter (BWL) and the other was for the NBI system. The
examinations were performed first with BWL illumin-
ation with a wide view to observe the whole lesion and
its surrounding mucosa. The same procedure was per-
formed with NBI illumination, and the capillaries were
analyzed in detail and recorded. The images were re-
corded and transferred to a hard drive in the computer.
Clinical characteristics revealed under BWL were ana-
lyzed first, and the intraepithelial papillary capillary loop
(IPCL) features under NBI illumination were observed
according to the IPCL classification of oral mucosa. The
IPCL classification for oral squamous epithelium was
created by dividing the findings into type I (normal mu-
cosa, regular brown dots), type II (IPCL pattern dilation
and crossing), type III (IPCL pattern elongation and
meandering) and type IV (IPCL pattern destruction andFig. 1 a Endoscopic examination of the left buccal oral erythroplakia of a 4
b NBI image from Fig. 1a. Regularly distributed intraepithelial papillary capi
was shown by NBI; the pathological report revealed squamous hyperplasiaangiogenesis following a sequence of carcinogenesis pro-
gression) [10]. Written informed consent was signed by
every patient, and then total excision by carbon dioxide
laser was performed under local anesthesia in the
operating room after endoscopic examination. Paraffin-
embedded specimens from these patients were collected
from the archives of the department of pathology.
Hematoxylin- and eosin-stained slides were reviewed by
two independent pathologists (L.-C.C. and C.-C.H.) to
confirm lesion diagnosis and to determine the final diag-
nosis. Epithelial dysplasia was diagnosed according to the
WHO 2005 classification [14]. Images from NBI were
reviewed by two independent otolaryngology specialists
(S.-W.Y. and T.-A.C.) to achieve agreement on the
morphology of intraepithelial microvasculature. In this
study, oral cavity erythroplakia was defined as flat, vel-
vety, sharply demarcated, homogeneous red plaque. Only
patients with oral homogeneous erythroplakia were en-
rolled. Exclusion criteria included oral erythroleukoplakia
(mix of both erythroplakia and leukoplakia), non-
homogeneous leukoplakia (including speckled, nodular,
and verrucous types), reddish exophytic mass with ulcer-
ation, and mucosa related to inflammatory or traumatic
etiologies. Analysis of the morphology of the microvascu-
lature patterns of oral erythroplakia was performed using
the three different reported criteria: (1) criteria I: brown-
ish spots and demarcation line with irregular micro-
vascular patterns (Figs. 1, 2) criteria II: well-demarcated
brownish area with thick dark spots and/or winding
vessels (Figs. 2, 3), and (3) criteria III: the intraepithelial
papillary capillary loop (IPCL) type III (IPCL pattern
elongation and meandering, (Figs. 4, 5), and type IV
(IPCL pattern destruction and angiogenesis following a
sequence of carcinogenesis progression, (Figs. 6, 7, 8)
[6,10,15–18]. If more than one IPCL type was detected
with NBI, the most advanced type detected was determined
as the IPCL type of the lesion. Each patient’s chart records
were reviewed, including their demographic data, site of the
lesion, morphology of the vascular architecture or the
IPCL, and histopathology. Using the histopathological5-year-old male patient with conventional broadband white light.
llary loop was demonstrated on the reddish patch, or IPCL type I,
Fig. 2 a Endoscopic examination of the right buccal erythroplakia of a 48-year-old male patient with conventional broadband white light. b NBI
image from Fig. 2a. Dilated and tortuous intraepithelial microvasculature, or IPCL type II, was shown by NBI; the pathological report revealed
intermediate-grade dysplasia
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sensitivity, specificity, positive predictive value, negative
predictive value, accuracy, false positive percentage, and
false negative percentage of endoscopy by NBI illumination
for detecting HGD/Tis/CA were calculated. Patient histor-
ies related to betel quid, alcohol and tobacco use were ob-
tained during our detailed questioning of the patients on
their first visit to the otolaryngology clinic of the hospital.
The criteria for a positive assignment were defined as previ-
ously described [19].Statistical analysis
Results are presented descriptively, including factors re-
lated to the pathological diagnosis of HGD/Tis/CA
which were grouped and analyzed using chi-square test.
Odds ratio (OR) and 95 % confidence intervals (CIs)
were calculated using a 2-tailed test of significance (p <
0.05) for each risk factor. We followed these parameters:
(1) when the 95 % CI did not include 1.0, the resulting
OR of the risk factor was statistically significant; (2) if
the value of the OR was greater than 1.0, the risk was
increased, and (3) if the value was less than 1.0, the
risk was reduced or protective. The Pearson’s linearFig. 3 a Endoscopic examination of the left tongue erythroplakia
of a 70-year-old male patient with conventional broadband white
light. b NBI image from Fig. 3a. Dilated and tortuous intraepithelial
microvasculature, or IPCL type II, was shown by NBI; the pathological
report revealed low-grade dysplasiacorrelation coefficient (Pearson’s r) between the path-
ology and endoscopic examination of oral leukoplakia
was calculated under the null hypothesis of both samples
of pairs showing the same correlation strength [20]. The
Fisher’s exact test, ANOVA, and Pearson’s r were calcu-
lated using the MATLAB program (Mathworks Inc.,
Natick, Mass., USA).
The predictions and diagnostic tests employed in this
study were in accordance with the method described by
Simel et al. [21]. The comparison between the two cri-
teria was made on the basis of the changes in the log-
odds ratio for the two tables with the standard Pearson
chi-square on a 2 × 4 table wherein each row was ob-
tained by treating each 2 × 2 table as a one-way table
with four cells. The statistical analyses were also con-
ducted using the MATLAB program.
Results
The medical records of 72 patients with oral erythropla-
kia who had received surgical treatment from April 2009
to April 2012 were retrospectively reviewed. Among
them were 66 males (91.7 %) and 6 females (8.3 %),
whose age ranged from 29 to 83 years, with an average
of 54.6 ± 11.2 years. High-grade dysplasia, carcinoma inFig. 4 a Endoscopic examination of the hard palate erythroplakia
of a 64-year-old male patient with conventional broadband white
light. b NBI image from Fig. 4a. Elongated and twisted intraepithelial
microvasculature, or IPCL type III, was shown by NBI; the pathological
report invasive squamous cell carcinoma
Fig. 5 a Endoscopic examination of the right buccal erythroplakia of a 65-year-old male patient with conventional broadband white light. b NBI
image from Fig. 5a. Elongated and twisted intraepithelial microvasculature, or IPCL type III, was demonstrated by NBI, whose pathological report
revealed high-grade dysplasia
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cases (29.1 %). All four cases of OSCC were stage I,
T1N0M0. The demographic and clinicopathological data
are shown in Table 1.
According to the clinical appearance under endoscopic
examination with conventional broadband white light,
all of the 72 patients had characteristic oral erythropla-
kia, including flat, bright red, velvety, often glistening,
rather sharply circumscribed, asymptomatic plaque
[13,22]. Using NBI illumination, six cases (8.3 %) pre-
sented as IPCL type I (Fig. 1), which were all squamous
hyperplasia pathologically; 38 cases (52.8 %) as IPCL
type II (Figs. 2, 3), squamous hyperplasia in five, low-
grade dysplasia in 18, intermediate-grade dysplasia in
11, and high-grade dysplasia in 4; 25 cases (34.7 %) as
IPCL type III (Figs. 4, 5), squamous hyperplasia
was found in one case, low-grade dysplasia in four,
intermediate-grade dysplasia in six, high-grade dyspla-
sia in 13, and squamous cell carcinoma in one; three
cases (4.2 %) as IPCL type IV (Figs. 6, 7, 8), all were
squamous cell carcinoma. The distribution between the
different types of IPCL by NBI system and different
pathological results with incremental severity areFig. 6 a Endoscopic examination of the left buccal erythroplakia
of a 39-year-old male patient with conventional broadband
white light. b NBI image from Fig. 6a. Intraepithelial papillary
capillary loop pattern destruction, or IPCL type IV, could be
clearly visualized with NBI illumination. The pathological report
showed squamous cell carcinomasummarized in Table 2 and Pearson’s linear correlation
coefficient was 0.70.
Among the 72 cases in total, 38 met criteria I, with
four having HGD/Tis/CA; 63 met criteria II, with 18
having HGD/Tis/CA; and 28 met criteria III, with 17
having HGD/Tis/CA. The odds ratio for criteria I, II,
and III were 0.12, 0.80, and 15.46, respectively. The de-
tection rate of HGD/Tis/CA was significantly higher
with NBI criteria III than with the other two criteria
(p < 0.001, Table 3).
The sensitivity, specificity, positive predictive value,
negative predictive value, accuracy, false positive per-
centage, and false negative percentage of NBI criteria III
for detecting the occurrence of squamous cell carcinoma
in oral erythroplakia were 80.95 %, 78.43 %, 60.71 %,
90.91 %, 79.17 %, 21.57 %, and 19.05 %, respectively.
Discussion
Erythroplakia is a sharply defined, bright red, velvety le-
sion described by Queyrat in 1911 as occurring on the
glans penis and representing a premalignant process, be-
cause of its frequent ultimate development of carcinoma
[13]. The exact time point for erythroplakia beingFig. 7 a Endoscopic examination of the right retromolar erythroplakia
with conventional broadband white light in a 44-year-old male patient
with conventional broadband white light. b NBI image from Fig. 7a.
Destructive pattern of intraepithelial microvasculature, or IPCL type IV,
was shown by NBI illumination. The pathological report was squamous
cell carcinoma
Fig. 8 a Endoscopic examination of the left ventral tongue erythroplakia with conventional broadband white light in a 56-year-old male patient
with conventional broadband white light. b NBI image from Fig. 8a. Destructive pattern of intraepithelial microvasculature, or IPCL type IV, was
shown by NBI illumination. The pathological report was squamous cell carcinoma
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disease is not well documented. A direct relationship be-
tween oral erythroplakia and the development of oral
cancer was not suggested until the 1960s and the 1970s
[22]. Oral erythroplakia has a range of prevalence
between 0.02 % and 0.83 %, which is far less than 0.2–
4.9 % for oral leukoplakia [22–24]. The term leukoplakia
is used to designate a clinical white patch or plaque on
the oral mucosa that cannot be removed by scraping and
cannot be classified clinically or microscopically as
another disease entity [25]. Queyrat used the term
“erythroplasie” to designate a red area analogously to the
French term “leukoplasie” [22]. The concept of erythro-
plakia is similar to that of leukoplakia; however, inflam-
matory or traumatic etiology should be excluded before
further diagnosing erythroplakia [26]. In terms of clinical
appearance, erythroplakia is different from leukoplakia
due to its absence of whitish patch, which was found to
be hyperkeratotic lesion under the microscope. Patho-
logically hyperkeratosis or parakeratosis was not found
in cases of oral erythroplakia in the present study. The
process of hyperkeratosis is involved in the pathogenic
process of leukoplakia, but the same process may not be
implicated in erythroplakia. In addition, the epithelium
of oral erythroplakia is often atrophic and shows lack of
keratinization [1,27]. Erythroplakia has the highest risk
of developing carcinoma, whereas this takes place less
frequently in oral leukoplakia [28]. In a study done by
Shafer et al., 91 % of erythroplakia biopsies revealed dys-
plasia, carcinoma in situ, or carcinoma pathologically
[13]. These distinct differences between these two dis-
ease entities are important because the majority of ery-
throplakia lesions represent precancerous or malignant
conditions of more serious magnitude.
Histopathological examination of erythroplakia is the
only method that can be used to determine if there is
concomitant dysplasia, carcinoma in situ, or carcinoma
within erythroplakia, which is also the same for oral leu-
koplakia. Before a surgical biopsy is conducted, epithelialstatus is generally not known. NBI is an endoscopic
technique based on distinctive optical filters that narrow
the light bandwidth to enhance the visualization of the
intraepithelial microvasculature of mucosa surface,
which rises perpendicularly from the branching vessel, is
barely recognizable under observation of normal epithe-
lium by BWL [10,18,29]. It has been shown to be helpful
in enhancing early detection of cancerous lesion in the
upper aerodigestive tract, including esophagus, pharynx,
and oral cavity; abnormal vascular architectures of NBI
of oral mucosa appear as increased number, tortuous, di-
lated, twisted, elongated, and corkscrew-type small blood
vessels of varying caliber [5,6,8–10,18,30]. Endoscope
with NBI has been employed to evaluate oral cavity leu-
koplakia, the most commonly seen oral precancerous le-
sion, and the diversiform intraepithelial microvascular
patterns shown by NBI is found to be a useful tool in
detecting high-grade dysplasia, carcinoma in situ, and
carcinoma in oral leukoplakia in our previous works
[5,6,8,9]. No correlation between the clinical appearance
of oral erythroplakia and the histopathology has ever
been provided so far. Since NBI is characterized by
enhancing visualization of the intraepithelial microvas-
culature, demonstration of microvascular architectures
beneath the mucosa epithelium under NBI illumination
may elucidate the relationship between the IPCL and
pathology of oral erythroplakia.
In the present study, only three cases were IPCL
type IV (destructive pattern of intraepithelial micro-
vasculature) and all of them were invasive carcinoma
(Figs. 6, 7, 8). Among the 25 cases of IPCL type III
(twisted and elongated pattern of intraepithelial mi-
crovasculature), 14 cases (56 %) were HGD/Tis/CA.
On the contrary, IPCL type I and type II were com-
posed of 44 cases, but only four (9.1 %) were HGD/
Tis/CA. The correlation between the different types of
intraepithelial microvasculature of NBI and patho-
logical results with step-by-step increased severity was
good (Pearson’s r = 0.7, Table 2).
Table 1 Clinicopathological characteristics of patients with oral









Lip 2 (2.8 %)
Buccal 55 (76.4 %)
Gum 1 (1.4 %)
Tongue 6 (8.3 %)
Palate 2 (2.8 %)
Floor of the mouth 2 (2.8 %)
Retromolar 4 (5.5 %)
Alcohol drinking
No 29 (40.3 %)
Ex-drinker 23 (31.9 %)
Yes 20 (27.8 %)
Cigarette smoking
No 14 (19.4 %)
Ex-smoker 19 (26.4 %)
Yes 39 (54.2 %)
Betel quid chewing
No 21 (29.2 %)
Ex-chewer 36 (50.0 %)
Yes 15 (20.8 %)
History of oral cancer
No 45 (62.5 %)
Yes 27 (37.5 %)
Intraepithelial microvasculature pattern by NBI
IPCL type I (regularly distributed arborescent
pattern of IPCL)
6 (8.3 %)
IPCL type II (tortuous and dilated pattern of IPCL) 38 (52.8 %)
IPCL type III (twisted and elongated pattern of IPCL) 25 (34.7 %)




Squamous hyperplasia 12 (16.7 %)
Low-grade dysplasia 22 (30.6 %)
Intermediate-grade of dysplasia 17 (23.6 %)
High-grade of dysplasia/carcinoma in situ 17 (23.6 %)
Squamous cell carcinoma 4 (5.5 %)
Abbreviation: NBI narrow-band imaging, IPCL intraepithelial papillary
capillary loop
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NBI have been utilized clinically. The characteristics of
these criteria was investigated and analyzed on oral leu-
koplakia in our previous work [6]. Criteria I consisted of
brownish spots and demarcation line with irregular
microvascular patterns, criteria II consisted of well-
demarcated brownish area with thick dark spots and/or
winding vessels, and criteria III consisted of elongation,
twist, and meandering destruction of IPCL pattern. In
this study, we further utilized these criteria to analyze
and compare the differences in oral erythroplakia.
Compared with leukoplakia, the observation of intrae-
pithelial microvasculature is more advantageous be-
cause the microvascular morphology of NBI is readily
observed (Figs. 1, 2, 3, 4, 5, 6, 7, 8). In the cases of oral
leukoplakia, the intraepithelial papillary capillary loop
can’t usually be observed owing to the fact that the
hyperkeratosis of oral leukoplakia obstructs the pene-
tration of light and the focus of observation has to be
emphasized on the mucosa around the whitish patch
[5,6,8,9]. It has been suggested that one of the reasons
why oral erythroplakia appears red under BWL in-
cluded attenuated and atrophic epithelium with a vas-
cular lamina propria lying close to the surface and the
connective tissue papillae containing engorged capil-
laries rising between rete ridges close to the surface
[13,22]. Significantly increased vascularity with disease
progression in oral cancer has been found in a study
by Carlie et al. In the study it was observed that an
alteration in IPCL patterns could be associated with
excessive angiogenesis in both premalignant and can-
cerous lesions [31,32]. The combination of engorged
capillaries with increased vascularity accounts for the
morphology of microvascular architectures under illu-
mination of NBI. The brownish spots with or without
winding vessels had been found to be used in detect-
ing carcinoma in situ in oropharynx and hypopharynx
mucosa [18] and cancer lesions in oral cavity [15],
however, the low odds ratio of NBI criteria I (OR =
0.12, CI95%: 0.03–0.40) and criteria II (OR = 0.80,
CI95%: 0.18–3.55) indicated that these patterns might
not be crucial indicators for HGD/Tis/CA in oral ery-
throplakia. Brownish areas detected by NBI, or criteria
I in this study, may represent benign pathologies such
as angiodysplasia, erosive changes of the mucosa, or
overlapping normal vascularity, each of which may
cause false positive results to be observed [33]. The
detection rate of HGD/Tis/CA of criteria III (OR =
15.46, CI95%: 3.81–72.84) was significantly better than
criteria I and II (p < 0.001, Table 3). According to the
results of the diagnostic tests by criteria III, the nega-
tive predictive value was 90.91 % but the positive
predictive value was 60.71 %. This finding of good
negative predictive value explained that the low














Morphology of NBI 0.70
IPCL type I 6 0 0 0 0
IPCL type II 5 18 11 4 0
IPCL type III 1 4 6 13 1
IPCL type IV 0 0 0 0 3
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pattern of IPCL was not shown by NBI. Early detec-
tion of HGD/Tis/CA is directly related to less aggres-
sive treatment and better prognosis. For those who are
not suitable to receive a biopsy or that are not willing
to undergo a surgical biopsy, NBI can be a promising,
fast, and safe tool to provide addition important infor-
mation regarding oral erythroplakia before surgical
intervention.
To the best of our knowledge, the current study is
the first to illustrate the correlation between the path-
ology and morphological pictures of NBI images in a
large series of patients. The images of NBI are appar-
ently subjective. Training to learn to observe the
morphology from all angles and avoid the inadvertent
light reflex from the mucus or debris of oral cavity
is mandatory. In a study done by Puxeddu et al.,Table 3 Statistical analysis of pathology, and NBI in detecting
high-grade dysplasia, carcinoma in situ, and invasive carcinoma
of oral erythroplakia (n = 72)
Non-HGD/Tis/CAa HGD/Tis/CA Odds ratio (CI 95 %)
Criteria I: Appearance of brownish spots
and demarcation line with irregular
microvascular patterns
p < 0.001*
No 17 17 1.00
Yes 34 4 0.12 (0.03–0.40)
Criteria II: Appearance of well-demarcated
brownish area with thick dark spots and/or
winding vessels
p < 0.001**
No 6 3 1.00
Yes 45 18 0.80 (0.18–3.55)
Criteria III: Elongation, twist, and meandering
destruction of IPCL pattern
-
No 40 4 1.00
Yes 11 17 15.46 (3.81–72.84)
Abbreviation: CI confidence interval
*Comparison between criteria I and criteria III
**Comparison between criteria II and criteria III
aNon-HGD/Tis/CA includes squamous hyperplasia, low-grade dysplasia and
intermediate-grade dysplasia histopathologicallycoupling of the NBI and Storz Professional Image
Enhancement System (SPIES) with contact endoscopy
for laryngeal and hypopharyngeal pathology a to mag-
nify the vascular pattern of the lesions examined and
reduce inter and intraobserver variations is a promi-
sing tool. The accuracy in the differential diagnosis
between normal tissue and hyperplasia versus mild
dysplasia and carcinoma is 97.6 % [34]. Further study
of application of this system to the oral cavity mucosal
lesions is warranted to improve the detection of
pathological dysplasia and carcinoma. Lack of univer-
sal diagnostic standards for NBI microvascular morph-
ology remains a challenge and large-scale prospective
study is warranted for further validation of this tool.
In addition, we are aware of some limitations of our
study. First, the sample size is small due to the low in-
cidence of oral erythroplakia and short time period for
case collection. Second, the histopathological epithe-
lial dysplasia is a spectrum, and currently no definite
criteria are established to clearly cut this spectrum
into low, intermediate, and high-grade. There may be
a substantial interobserver and intraobserver variation
in the assessment of the grade of epithelial dysplasia
[14]. We attempted to reduce the above-mentioned
variation by using immunohistochemical staining with
Ki-67 mouse monoclonal antibody, in some of the
cases, and by asking two pathologists to reach agree-
ment on every case. The third limitation is the retro-
spective nature of the study. Large-scale, multi-center,
or international cross-country research is required to
achieve a more definite conclusion.Conclusion
Twisted elongated and destructive patterns of intrae-
pithelial microvasculature of NBI images are crucial in-
dicators for detecting high-grade dysplasia, carcinoma in
situ, and invasive carcinoma in oral erythroplakia in the
current study. The findings suggest that endoscopy with
NBI may serve as a non-invasive procedure to provide
adjunctive information in identifying HGD/Tis/CA in
oral erythroplakia.
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